Cargando…
Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis
BACKGROUND: Blepharospasm is a focal cranial dystonia, which could be idiopathic in origin or secondary to an underlying disorder that commonly impairs quality of life. Botulinum toxin (BoNT) injections have become the treatment of choice; however, a less favorable response to BoNT is expected in se...
Autores principales: | Martinez-Ramirez, Daniel, Giugni, Juan C., Hastings, Erin, Shukla, Aparna Wagle, Malaty, Irene A., Okun, Michael S., Rodriguez, Ramon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia University Libraries/Information Services
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266684/ https://www.ncbi.nlm.nih.gov/pubmed/25562037 http://dx.doi.org/10.7916/D8H41Q4X |
Ejemplares similares
-
Occurrence of Dysphagia Following Botulinum Toxin Injection in Parkinsonism-related Cervical Dystonia: A Retrospective Study
por: Patterson, Addie, et al.
Publicado: (2016) -
Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014) -
Injecting botulinum toxin into the
treatment of blepharospasm
por: Popescu, Marius Nicolae, et al.
Publicado: (2018) -
High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy
por: Chiu, Shannon Y., et al.
Publicado: (2020) -
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
por: Hassell, Travis J.W., et al.
Publicado: (2020)